Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GB:GSK)
LSE:GSK
Earnings Data
Report Date
Oct 29, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.47Last Year’s EPS
0.5Same Quarter Last Year
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance by GSK with significant growth in specialty medicines and positive advancements in R&D. Despite challenges in the Chinese market and cost pressures, the company remains confident in reaching the top end of its financial guidance for the year.Company Guidance
Strong Financial Performance
Group sales increased by 6% for the quarter, core operating profit rose by 12%, and core earnings per share grew 15% to 46.5p. Cash generation was notably positive with GBP 3.7 billion generated in the first half.
Specialty Medicines Growth
Specialty Medicines segment saw a significant increase in sales, up 15%, contributing to the overall sales growth and highlighting the success of the new innovations in the portfolio.
Progress in R&D
Three FDA approvals achieved so far this year. Significant advancements in the pipeline with 14 scale opportunities identified and ongoing pivotal trials for various promising therapies.
Vaccine Sales Increase
Vaccine sales grew by 9%, supported by demand for Shingrix, which saw a 6% increase, and strong growth in meningitis vaccines.
Positive Outlook
The company expects to reach the top end of financial guidance for 2025, indicating continued confidence in performance and growth trajectory.
GB:GSK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:GSK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2025 | 1399.37p | 1449.70p | +3.60% |
Feb 05, 2025 | 1333.55p | 1435.01p | +7.61% |
Oct 30, 2024 | 1387.19p | 1344.67p | -3.07% |
Jul 31, 2024 | 1460.32p | 1431.45p | -1.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does GlaxoSmithKline (GB:GSK) report earnings?
GlaxoSmithKline (GB:GSK) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).
What is GlaxoSmithKline (GB:GSK) earnings time?
GlaxoSmithKline (GB:GSK) earnings time is at Oct 29, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of GlaxoSmithKline stock?
The P/E ratio of GlaxoSmithKline is N/A.
What is GB:GSK EPS forecast?
GB:GSK EPS forecast for the fiscal quarter 2025 (Q3) is 0.47.